A. Perl, P. J. Gergely, F. Puskas, and K. Banki, Metabolic switches of T-cell activation and apoptosis, Antioxidants Redox Signal, vol.4, pp.427-443, 2002.

E. Solary, L. Dubrez, and B. Eymin, The role of apoptosis in the pathogenesis and treatment of diseases, Eur. Respir. J, vol.9, pp.1293-1305, 1996.

C. B. Thompson, Apoptosis in the pathogenesis and treatment of disease, Science, vol.267, pp.1456-1462, 1995.

Y. Sun, E3 ubiquitin ligases as cancer targets and biomarkers, Neoplasia, vol.8, pp.645-654, 2006.

A. M. Hunter, E. C. Lacasse, and R. G. Korneluk, The inhibitors of apoptosis (IAPs) as cancer targets, Apoptosis, vol.12, pp.1543-1568, 2007.

D. Faustman and M. Davis, TNF receptor 2 pathway: Drug target for autoimmune diseases, Nat. Rev. Drug Discov, vol.9, pp.482-493, 2010.

E. Paplomata and R. O'regan, The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers, Ther. Adv. Med. Oncol, vol.6, pp.154-166, 2014.

F. Isono, S. Fujita-sato, and S. Ito, Inhibiting ROR?t/Th17 axis for autoimmune disorders, Drug Discov. Today, vol.19, pp.1205-1211, 2014.

A. Nayak, S. R. Satapathy, D. Das, S. Siddharth, N. Tripathi et al., Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1, Sci. Rep, vol.6, 2016.

S. Das, N. Tripathi, R. Preet, S. Siddharth, A. Nayak et al., Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade, Oncotarget, vol.8, pp.248-267, 2017.

S. Das, N. Tripathi, S. Siddharth, A. Nayak, D. Nayak et al., Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis, Apoptosis, vol.22, pp.1205-1224, 2017.

P. Fasching, M. Stradner, W. Graninger, C. Dejaco, and J. Fessler, Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders, Molecules, vol.22, 2017.

G. Sala, F. Dituri, C. Raimondi, S. Previdi, T. Maffucci et al., Phospholipase C?1 is required for metastasis development and progression, Cancer Res, vol.68, pp.10187-10196, 2008.

Y. R. Yang, J. H. Choi, J. Chang, H. M. Kwon, H. Jang et al., Diverse cellular and physiological roles of phospholipase C-?1, Adv. Enzyme Regul, vol.52, pp.138-151, 2012.

R. Lattanzio, M. Piantelli, and M. Falasca, Role of phospholipase C in cell invasion and metastasis, Adv. Biol. Regul, vol.53, pp.309-318, 2013.

A. Poissonnier, J. P. Guégan, H. T. Nguyen, D. Best, N. Levoin et al., Disrupting the CD95-PLC?1 interaction prevents Th17-driven inflammation, Nat. Chem. Biol, vol.14, pp.1079-1089, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01976911

G. Kadamur, E. M. Ross, and C. Mammalian-phospholipase, Annu. Rev. Physiol, vol.75, pp.127-154, 2012.

L. Deng, C. A. Velikovsky, C. P. Swaminathan, S. Cho, R. A. Mariuzza et al., Structural basis for recognition of the T Cell adaptor protein SLP-76 by the SH3 domain of phospholipase C?1, J. Mol. Biol, vol.352, pp.1-10, 2005.

P. Gierschik, A. Buehler, and C. Walliser, Activated PLC? breaking loose, Structure, vol.20, 1989.

T. D. Bunney, D. Esposito, C. Mas-droux, E. Lamber, R. W. Baxendale et al., Structural and functional integration of the PLC? interaction domains critical for regulatory mechanisms and signaling deregulation, Structure, vol.20, pp.2062-2075, 2012.

H. Koss, T. D. Bunney, S. Behjati, and M. Katan, Dysfunction of phospholipase C? in immune disorders and cancer, Trends Biochem. Sci, vol.39, pp.603-611, 2014.

W. Tang, Y. Zhou, D. Sun, L. Dong, J. Xia et al., Oncogenic role of PLCG1 in progression of hepatocellular carcinoma, Hepatol. Res, vol.49, pp.559-569, 2019.

C. Wu, M. H. Ma, K. R. Brown, M. Geisler, L. Li et al., Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening, Proteomics, vol.7, pp.1775-1785, 2007.

P. S. Huang, L. Davis, H. Huber, P. J. Goodhart, R. E. Wegrzyn et al., An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-?1, FEBS Lett, vol.358, pp.287-292, 1995.

M. R. Smith, Y. L. Liu, S. R. Kim, Y. S. Bae, C. G. Kim et al., PLCy1 Src homology domain induces mitogenesis in quiescent NIH 3T3 fibroblasts, Biochem. Biophys. Res. Commun, vol.222, pp.186-193, 1996.

K. Seedorf, G. Kostka, R. Lammers, P. Bashkin, R. Daly et al., Dynamin binds to SH3 domains of phospholipase C? and GRB-2, J. Biol. Chem, vol.269, pp.16009-16014, 1994.

D. B. Kitchen, H. Decornez, J. R. Furr, and J. Bajorath, Docking and scoring in virtual screening for drug discovery: Methods and applications, Nat. Rev. Drug Discov, vol.3, pp.935-949, 2004.

S. K. Kwofie, B. Dankwa, K. S. Enninful, C. Adobor, E. Broni et al., Molecular docking and dynamics simulation studies predict munc18b as a target of mycolactone: A plausible mechanism for granule exocytosis impairment in Buruli Ulcer Pathogenesis, Toxins

R. C. Wade and O. M. Salo-ahen, Molecular Modeling in Drug Design, Molecules, vol.24, p.321, 2019.

S. Q. Wang, Q. S. Du, R. B. Huang, D. W. Zhang, and K. C. Chou, Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus, Biochem. Biophys. Res. Commun, vol.386, pp.432-436, 2009.

X. B. Li, S. Q. Wang, W. R. Xu, R. L. Wang, and K. C. Chou, Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method, PLoS ONE, vol.6, 2011.

Y. Ma, S. Q. Wang, W. R. Xu, R. L. Wang, and K. C. Chou, Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach, PLoS ONE, vol.7, 2012.

S. Franchini, U. M. Battisti, A. Prandi, A. Tait, C. Borsari et al., Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives, Eur. J. Med. Chem, vol.112, pp.1-19, 2016.

S. Franchini, L. Manasieva, C. Sorbi, U. Battisti, P. Fossa et al., Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro-and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists, Eur. J. Med. Chem, vol.125, pp.435-452, 2017.

N. Ghamari, O. Zarei, D. Reiner, S. Dastmalchi, H. Stark et al., Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects, Chem. Biol. Drug Des, vol.93, pp.832-843, 2019.

J. N. Selvakumar, S. D. Chandrasekaran, G. P. Doss, and T. D. Kumar, Inhibition of the ATPase Domain of Human Topoisomerase IIa on HepG2 Cells by 1, 2-benzenedicarboxylic Acid, Mono (2-ethylhexyl) Ester: Molecular Docking and Dynamics Simulations, Curr. Cancer Drug Targets, vol.19, pp.495-503, 2019.

A. Gaulton, L. J. Bellis, A. P. Bento, J. Chambers, M. Davies et al., ChEMBL: A large-scale bioactivity database for drug discovery, Nucleic Acids Res, vol.40, pp.1100-1107, 2012.

S. L. Dixon, A. M. Smondyrev, E. H. Knoll, S. N. Rao, D. E. Shaw et al., PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results, J. Comput. Aided. Mol. Des, vol.20, pp.647-671, 2006.

S. L. Dixon, A. M. Smondyrev, and S. N. Rao, PHASE: A novel approach to pharmacophore modeling and 3D database searching, Chem. Biol. Drug Des, vol.67, pp.370-372, 2006.

. Schrödinger, , 2018.

L. Schrödinger, , 2018.

M. Sastry, G. Adzhigirey, M. Day, T. Annabhimoju, R. Sherman et al., Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments, J. Comput. Aided. Mol. Des, vol.27, pp.221-234, 2013.

. Schrödinger, , 2018.

L. Schrödinger, , 2016.

. Schrödinger, , 2018.

L. Schrödinger, , 2018.

J. C. Shelley, A. Cholleti, L. L. Frye, J. R. Greenwood, M. R. Timlin et al., Epik: A software program for pKa prediction and protonation state generation for drug-like molecules, J. Comput. Aided. Mol. Des, vol.21, pp.681-691, 2007.

J. R. Greenwood, D. Calkins, A. P. Sullivan, and J. C. Shelley, Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution, J. Comput. Aided. Mol. Des, vol.24, pp.591-604, 2010.

. Schrödinger, , 2018.

L. Schrödinger, , 2018.

R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic et al., Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem, vol.47, pp.1739-1749, 2004.

T. A. Halgren, R. B. Murphy, R. A. Friesner, H. S. Beard, L. L. Frye et al., Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem, vol.47, pp.1750-1759, 2004.

R. A. Friesner, R. B. Murphy, M. P. Repasky, L. L. Frye, J. R. Greenwood et al., Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J. Med. Chem, vol.49, pp.6177-6196, 2006.

. Schrödinger, , 2018.

L. Schrödinger, , 2018.

W. Sherman, T. Day, M. P. Jacobson, R. A. Friesner, and R. Farid, Novel procedure for modeling ligand/receptor induced fit effects, J. Med. Chem, vol.49, pp.534-553, 2006.

W. Sherman, H. S. Beard, and R. Farid, Use of an induced fit receptor structure in virtual screening, Chem. Biol. Drug Des, vol.67, pp.83-84, 2006.

, Schrödinger Release 2018-2: Induced Fit Docking protocol; Glide

L. Schrödinger, , 2016.

W. L. Jorgensen, D. S. Maxwell, and J. Tirado-rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc, vol.118, pp.11225-11236, 1996.

. Schrödinger, , 2018.

L. Schrödinger, , 2018.

D. A. Case, I. Y. Ben-shalom, S. R. Brozell, D. S. Cerutti, T. E. Cheatham et al., , 2018.

J. Wang, R. M. Wolf, J. W. Caldwell, P. A. Kollman, and D. A. Case, Development and testing of a general Amber force field, J. Comput. Chem, vol.25, pp.1157-1174, 2004.

V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg et al., Comparison of multiple amber force fields and development of improved protein backbone parameters, Proteins Struct. Funct. Genet, vol.65, pp.712-725, 2006.

A. Jakalian, D. B. Jack, and C. I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comput. Chem, vol.21, pp.132-146, 2002.

P. Mark and L. Nilsson, Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K, J. Phys. Chem. A, vol.105, pp.9954-9960, 2001.

T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems, J. Chem. Phys, vol.98, pp.10089-10092, 1993.

T. R. Forester, W. Smith, and . Shake, Efficient constraint algorithms for linked rigid bodies, J. Comput. Chem, vol.19, pp.102-111, 1998.

D. R. Roe, T. E. Cheatham, and C. Ptraj, Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput, vol.9, pp.3084-3095, 2013.

W. Humphrey, A. Dalke, and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph, vol.14, pp.33-38, 1996.

S. Genheden and U. Ryde, The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities, Expert Opin. Drug Discov, vol.10, pp.449-461, 2015.

, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI